RHYTHM PHARMACEUTICALS INC's ticker is RYTM and the CUSIP is 76243J105.
Links
Filings
- All filings
- Annual reports (20-F)
- Quarterly reports (6-K)
- Insider transactions
- Shareholder votes
- Significant ownership
- Events
EDGAR links
External links
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $276,000 | +130.0% | 12,043 | +66.1% | 0.00% | – |
| Q2 2023 | $120,000 | +242.9% | 7,249 | +269.3% | 0.00% | – |
| Q1 2023 | $35,000 | +600.0% | 1,963 | +1028.2% | 0.00% | – |
| Q4 2022 | $5,000 | +150.0% | 174 | +167.7% | 0.00% | – |
| Q3 2022 | $2,000 | -93.8% | 65 | -97.7% | 0.00% | – |
| Q1 2022 | $32,000 | -62.4% | 2,796 | -67.2% | 0.00% | – |
| Q4 2021 | $85,000 | +41.7% | 8,531 | +86.3% | 0.00% | – |
| Q3 2021 | $60,000 | -27.7% | 4,580 | +8.6% | 0.00% | – |
| Q2 2021 | $83,000 | +2.5% | 4,217 | +10.5% | 0.00% | – |
| Q1 2021 | $81,000 | +305.0% | 3,815 | +482.4% | 0.00% | – |
| Q4 2020 | $20,000 | +400.0% | 655 | +227.5% | 0.00% | – |
| Q3 2020 | $4,000 | +100.0% | 200 | +65.3% | 0.00% | – |
| Q1 2020 | $2,000 | -95.0% | 121 | -93.1% | 0.00% | – |
| Q4 2019 | $40,000 | – | 1,752 | +34940.0% | 0.00% | – |
| Q1 2019 | $0 | – | 5 | +150.0% | 0.00% | – |
| Q4 2018 | $0 | -100.0% | 2 | -99.5% | 0.00% | – |
| Q3 2018 | $12,000 | +1100.0% | 426 | +826.1% | 0.00% | – |
| Q2 2018 | $1,000 | -66.7% | 46 | -56.6% | 0.00% | – |
| Q4 2017 | $3,000 | – | 106 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| NEA Management Company, LLC | 4,909,956 | $142,977,919 | 8.04% |
| Opaleye Management Inc. | 735,000 | $21,403,200 | 7.44% |
| Frazier Life Sciences Management, L.P. | 1,894,000 | $55,153,280 | 3.43% |
| RA Capital Management | 5,516,067 | $160,627,871 | 3.26% |
| Altium Capital Management LP | 170,000 | $4,950,400 | 2.52% |
| Samsara BioCapital, LLC | 345,293 | $10,054,932 | 2.16% |
| Rock Springs Capital Management LP | 1,760,865 | $51,276,389 | 1.23% |
| Parkman Healthcare Partners LLC | 157,862 | $4,596,941 | 1.22% |
| Baker Brothers Advisors | 6,354,608 | $185,046,185 | 1.11% |
| EAM Investors, LLC | 164,695 | $4,795,918 | 0.99% |